Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
For decades, Alzheimer's research has focused on examining amyloid plaques in the brain and prescribing antibody therapeutics that remove the plaques to slow cognitive decline in patients.
A new study from Columbia University shows that combining a brief smell test with a short memory exam can predict cognitive ...
How do we distinguish threat from safety? It's an important question not just in our daily lives, but for human disorders ...
Several top INDIA bloc leaders are likely to attend the swearing-in ceremony of Omar Abdullah including Congress top brass ...
The pharmaceutical industry, with its focus on cutting-edge research and holistic treatment approaches, will be instrumental in shaping the future of care for these interconnected conditions ...
New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or ...